Form 4: Omnicell CEO Randall Lipps Reports Share Transactions

Omnicell's CEO, Randall Lipps, reported the acquisition and disposal of company shares, including those held in trust, following the vesting of restricted stock units.

Summary

• Randall Lipps, the Chairman, President, and CEO of Omnicell, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• The transactions occurred on November 15, 2024.
• Mr. Lipps directly disposed of 1,155 shares of common stock at a price of $45.67 per share to cover taxes related to vesting restricted stock units.
• He also indirectly owns 355,861 shares held in trust with his wife and 8,051 shares held in trust for his children.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing for corporate insiders and is a normal part of the regulatory process.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States.
• The transactions are typical for executives who receive stock-based compensation.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a routine sale of shares to cover taxes.

Key Dates

Keywords

Omnicell, Randall Lipps, Form 4, insider trading, share transaction, beneficial ownership, restricted stock units, stock disposal